医薬品用ゼラチンの世界市場予測(〜2025):ソース別(ブタ、ウシ皮、ウシ骨、魚、家禽)、用途別(ハードカプセル、ソフトカプセル、タブレット、吸収性止血鉗子)、機能別(安定化、増粘、ゲル化)、地域別

◆英語タイトル:Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025
◆商品コード:PH 7750
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年10月20日
◆ページ数:190
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Marketsandmarkets社は医薬品用ゼラチンの世界市場が2020年10億ドルから2025年12億ドルまで、年平均5.3%成長すると展望しています。本調査レポートでは、医薬品用ゼラチンの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場インサイト、用途別(ハードカプセル、ソフトカプセル、錠剤、吸収性止血剤、その他)分析、原料別(ブタ、ウシ皮、ウシ骨、魚、家禽)分析、機能別(ブルームバリュー、安定剤、増粘剤、ゲル剤・その他)分析、タイプ別(タイプB、タイプA)分析、地域別分析、競争状況、企業評価・情報など、以下の構成でお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場インサイト
・医薬品用ゼラチンの世界市場規模:用途別(ハードカプセル、ソフトカプセル、錠剤、吸収性止血剤、その他)
・医薬品用ゼラチンの世界市場規模:原料別(ブタ、ウシ皮、ウシ骨、魚、家禽)
・医薬品用ゼラチンの世界市場規模:機能別(ブルームバリュー、安定剤、増粘剤、ゲル剤・その他)
・医薬品用ゼラチンの世界市場規模:タイプ別(タイプB、タイプA)
・医薬品用ゼラチンの世界市場規模:地域別
・競争状況
・企業評価・情報
【レポートの概要】

“The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD1.0 billion in 2020, at a CAGR of 5.3% during the forecast period.” Growth in this market is driven by the advantages of pharmaceutical gelatin such as utility and versatility in medical and biomedical applications, unique functional properties, natural source of origin, and the increasing demand for pharmaceutical applications such as hard capsules and softgel capsules. However, factors such as cultural restrictions in consumption of porcine or bovine-derived gelatin, and rising prices of raw material are expected to restrain the growth of this market to a certain extent during the forecast period.

“The hard capsules segment holds the highest market share, by application, in the forecast period.”
On the basis of application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The hard capsules segment is expected to hold the highest share in the pharmaceutical gelatin market during the forecast period. Growth in this segment is largely driven by the stability, safety, security and efficacy provided by gelatin in hard capsules, and suitability of gelatin hard capsules for immediate-release dosing.

“Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth for this segment.”
On the basis of source, the pharmaceutical gelatin market is further segmented into porcine, bovine skin, bovine bone, marine & poultry. The bovine bone segment is projected to witness the highest growth in the pharmaceutical gelatin market, by source, during the forecast period. Bovine bone is suitable for use across a range of pharmaceutical applications including hard and softgel capsules, tablets, gelatin sponges, and plasma expanders due to its low Bloom and high viscosity. The high viscosity to Bloom ratio of bovine bone is especially advantageous in the manufacture of softgel capsules. These factors are accelerating the growth of this segment during the forecast period.

“By function, the stabilizing agent segment holds the highest market share in the pharmaceutical gelatin market”
On the basis of function, the pharmaceutical gelatin market is further segmented into stabilizing agent, thickening agent, gelling agent & other functions. The stabilizing agent segment is expected to hold the highest share in the pharmaceutical gelatin market, by source, during the forecast period. Gelatin has the ability to reduce surface and interfacial tensions, adsorb on to solid surfaces, and enhance the stability of oil-in-water emulsions, moreover, film formation by gelatin can stabilize surface interfaces by forming a film. These effects are utilized in the stabilization of emulsions in pharmaceutical applications and can be attributed to the large market share of this segment during the forecast period.

“By type, Type A pharmaceutical gelatin is growing at the fastest rate in the forecast period”
On the basis of type, the pharmaceutical gelatin market is further segmented into Type A and Type B. The Type A segment relates mainly to porcine gelatin. The Type A process for porcine gelatin requires shorter time for pre-treatment prior to the extraction of gelatin and minimizes the generation of waste water. These factors are projected to drive the growth of the Type A segment during the forecast period.

“North American region holds the highest market share in the pharmaceutical gelatin market”
North America is expected to account for the largest share of the global pharmaceutical gelatin market in 2019. The large share of the North American region is due to the demand for gelatin for applications in the pharmaceutical industry, easy availability of raw material in the region and business presence of a large number of market players in the region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–36%, Tier 2–39%, and Tier 3–25%
• By Designation: C-level–23%, Director Level–36%, and Others–41%
• By Region: North America–40%, Europe–15%, Asia Pacific–29%, Latin America- 8%, Middle East & Africa – 8%

The prominent players in the global pharmaceutical gelatin market are Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), Trobas Gelatine B.V. (Netherlands), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals. (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Junca Gelatines (Spain), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada).

Research Coverage:
The report analyzes the market for various pharmaceutical gelatin market and their adoption pattern. It aims at estimating the market size and future growth potential of the global pharmaceutical gelatin market and different segments such as application, source, type, function and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global pharmaceutical gelatin market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global pharmaceutical gelatin market
• Market Development: Comprehensive information on the lucrative emerging regions by products, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global pharmaceutical gelatin market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global pharmaceutical gelatin market

【レポートの目次】

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE PHARMACEUTICAL GELATIN MARKET 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 26
1.4.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 26
1.5 LIMITATIONS 26
1.6 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH APPROACH 27
FIGURE 1 RESEARCH DESIGN 27
2.1.1 SECONDARY RESEARCH 28
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY RESEARCH 29
2.1.3 PRIMARY SOURCES 29
2.1.3.1 Key data from primary sources 30
2.1.3.2 Breakdown of Primaries 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 31
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019) 31
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019) 32
FIGURE 5 SUPPLY SIDE ANALYSIS: PHARMACEUTICAL GELATIN MARKET (2019) 32
FIGURE 6 APPROACH 3: BASED ON SOURCE, BY REGION (2019) 33
FIGURE 7 APPROACH 4: BASED ON RAW MATERIAL UTILIZATION IN GELATIN EMPTY CAPSULES 34
FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 35
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PHARMACEUTICAL GELATIN MARKET (2020-2025) 36
2.3 DATA TRIANGULATION APPROACH 37
FIGURE 10 DATA TRIANGULATION METHODOLOGY 37
2.4 MARKET SHARE ESTIMATION 37
2.5 ASSUMPTIONS FOR THE STUDY 38
2.6 COVID-19 HEALTH ASSESSMENT 38
2.7 COVID-19 ECONOMIC ASSESSMENT 39
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 39
FIGURE 11 CRITERIA IMPACTING THE GLOBAL ECONOMY 39
FIGURE 12 SCENARIOS OF THE RECOVERY OF THE GLOBAL ECONOMY 40
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE PHARMACEUTICAL GELATIN MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 13 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 42
FIGURE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE,
2020 VS. 2025 (USD MILLION) 43
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PHARMACEUTICAL GELATIN MARKET 44
4 PREMIUM INSIGHTS 45
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW 45
FIGURE 16 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS DRIVING MARKET GROWTH 45
4.2 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 46
FIGURE 17 INDIA PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 46
4.3 REGIONAL MIX: PHARMACEUTICAL GELATIN MARKET (2020–2025) 47
FIGURE 18 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020–2025) 47
4.4 PHARMACEUTICAL GELATIN MARKET: DEVELOPED VS. EMERGING MARKETS,
2020 VS. 2025 (USD MILLION) 47
FIGURE 19 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING THE STUDY PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
FIGURE 20 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
5.2.1 DRIVERS 49
5.2.1.1 Versatility and superiority of gelatin in pharmaceutical applications 49
FIGURE 21 MEAN PERCENTAGE OF RIBOFLAVIN RELEASED FROM GELATIN, HPMC
(1ST GENERATION), AND PULLULAN CAPSULES IN 0.1 M HCL BUFFER 49
5.2.1.2 Gelatin is an all-natural product fulfilling pharmaceutical regulations 50
5.2.2 RESTRAINTS 50
5.2.2.1 Increasing popularity of veganism 50
FIGURE 22 UK: RISING TREND OF VEGANISM FROM 2014 TO 2019 (‘000) 51
5.2.2.2 Cultural restrictions limit the growth of pharmaceutical gelatin in certain regions 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Rising demand for pharmaceutical-grade gelatin in emerging countries 51
5.2.3.2 Enhancements in the properties of gelatin broaden the scope of its pharmaceutical applications 52
5.2.4 CHALLENGES 52
5.2.4.1 Increasing incidences of animal-borne diseases 52
FIGURE 23 CHINA: PORK IMPORTS (2018-2020) 53
FIGURE 24 CHINA: PER CAPITA PORK AVAILABILITY PER PERSON (2018-2020) 53
5.2.4.2 Rising prices and poor availability of raw materials 53
5.3 PORTER’S FIVE FORCES ANALYSIS 54
TABLE 1 PORTER’S FIVE FORCES ANALYSIS 54
5.3.1 THREAT OF NEW ENTRANTS 55
5.3.2 THREAT OF SUBSTITUTES 55
5.3.3 BARGAINING POWER OF SUPPLIERS 56
5.3.4 BARGAINING POWER OF BUYERS 56
5.3.5 COMPETITIVE RIVALRY 56
5.4 TRENDS IN AVERAGE SELLING PRICE 56
TABLE 2 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION,
2019-2020 57
5.5 VALUE CHAIN ANALYSIS 57
FIGURE 25 VALUE CHAIN ANALYSIS: PHARMACEUTICAL GELATIN MARKET 58
5.5.1 SOURCING OF RAW MATERIAL 58
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL 58
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING 58
5.5.4 GELATIN PRODUCTION 58
5.5.5 DISTRIBUTION TO END USERS 59
5.6 ECOSYSTEM MAP 59
FIGURE 26 ECOSYSTEM: PHARMACEUTICAL GELATIN MARKET 59
5.6.1 INTRODUCTION 59
5.6.2 FARMING INPUT 59
5.6.3 FARMING 59
5.6.4 SLAUGHTERING 59
5.6.5 MANUFACTURING 60
5.6.6 SUPPLIERS/DISTRIBUTORS 60
5.6.7 END-PRODUCT MANUFACTURERS 60
5.7 KEY MARKETS FOR IMPORT/EXPORT 60
5.7.1 US 60
5.7.2 CHINA 60
5.7.3 BRAZIL 60
TABLE 3 IMPORTS & EXPORTS OF GELATIN, BY COUNTRY: (2018/2019)
UNITS – 1,000 TONS 61
6 INDUSTRY INSIGHTS 62
6.1 INTRODUCTION 62
6.2 INDUSTRY TRENDS 62
6.2.1 PRODUCT INNOVATIONS OVERCOME CROSSLINKING OF GELATIN 62
6.2.2 INCREASING BIOMEDICAL APPLICATIONS OF GELATIN 62
6.2.3 INSIGHTS ON THE CONVERSION OF GELATIN TO COLLAGEN PEPTIDE AND PHARMACEUTICAL GELATIN 63
6.3 IMPACT OF THE COLLAGEN PEPTIDES MARKET ON PHARMACEUTICAL GELATIN 64
6.4 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET 65
6.5 REGULATORY ANALYSIS 66
7 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION 68
7.1 INTRODUCTION 69
TABLE 4 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 69
7.2 HARD CAPSULES 69
7.2.1 COST-EFFECTIVITY OF GELATIN HARD CAPSULES DRIVES THE GROWTH OF THIS SEGMENT 69
TABLE 5 TYPICAL HARD GELATIN CAPSULE COMPOSITION 69
TABLE 6 DIMENSIONS (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES 70
TABLE 7 HARD CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 71
7.3 SOFTGEL CAPSULES 71
7.3.1 RISING APPLICATIONS OF SOFTGEL CAPSULES INCREASE THEIR DEMAND IN THE PHARMACEUTICAL GELATIN MARKET 71
TABLE 8 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES 72
TABLE 9 SOFTGEL CAPSULES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 73
7.4 TABLETS 73
7.4.1 THE APPLICATION OF GELATIN IN TABLET BINDING AND COATING IS EXPECTED TO INCREASE DURING THE FORECAST PERIOD 73
TABLE 10 IN VITRO PROPERTIES OF TABLET WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%) 74
TABLE 11 TABLETS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 74
7.5 ABSORBABLE HEMOSTATS 75
7.5.1 INCREASING APPLICATIONS OF GELATIN IN ABSORBABLE HEMOSTATS DUE TO BIOCOMPATIBILITY TO DRIVE THE GROWTH OF THIS SEGMENT 75
TABLE 12 ABSORBABLE HEMOSTATS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 75
7.6 OTHER APPLICATIONS 76
7.6.1 VERSATILITY OF GELATIN DUE TO ITS UNIQUE FUNCTIONAL PROPERTIES BOOSTS ITS SCOPE FOR APPLICATIONS ACROSS THE PHARMACEUTICAL INDUSTRY 76
TABLE 13 OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 77
7.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY APPLICATION 77
8 PHARMACEUTICAL GELATIN MARKET, BY SOURCE 78
8.1 INTRODUCTION 79
8.1.1 GELATIN: REGULATIONS IMPLEMENTED BY DIFFERENT REGIONS/COUNTRIES 79
TABLE 14 PHARMACEUTICAL GELATIN MARKET, BY SOURCE,
2018–2025 (USD MILLION) 79
TABLE 15 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018–2025 (KT) 80
8.2 PORCINE 80
8.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIAL TO DRIVE THE GROWTH OF THIS SEGMENT 80
TABLE 16 US: PORK EXPORTS IN USD MILLION (2019) 81
TABLE 17 PORCINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 18 PORCINE MARKET, BY REGION, 2018–2025 (KT) 82
8.3 BOVINE SKIN 82
8.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST APPLICATION IN THE PHARMACEUTICAL GELATIN MARKET 82
TABLE 19 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(NUMBER OF PIECES) 83
TABLE 20 US: EXPORT STATISTICS FOR BOVINE FRESH/WET SALTED HIDES
(VALUE IN USD THOUSAND) 83
TABLE 21 BOVINE SKIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 22 BOVINE SKIN MARKET, BY REGION, 2018–2025 (KT) 84
8.4 BOVINE BONE 85
8.4.1 RISING PREFERENCE FOR BOVINE BONE AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET DUE TO LOW BLOOM AND HIGH VISCOSITY 85
TABLE 23 BOVINE BONE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 24 BOVINE BONE MARKET, BY REGION, 2018–2025 (KT) 86
8.5 MARINE 87
8.5.1 RISING INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE THE GROWTH OF MARINE SOURCE IN THE PHARMACEUTICAL GELATIN MARKET 87
TABLE 25 MARINE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 87
TABLE 26 MARINE MARKET, BY REGION, 2018–2025 (KT) 88
8.6 POULTRY 88
8.6.1 STEADY AVAILABILITY OF POULTRY AS RAW MATERIAL IS EXPECTED TO BOOST UTILITY AS RAW MATERIAL IN THE PHARMACEUTICAL GELATIN MARKET 88
TABLE 27 AMINO ACID COMPOSITION OF GELATIN FROM DIFFERENT SOURCES 88
TABLE 28 POULTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 29 POULTRY MARKET, BY REGION, 2018–2025 (KT) 89
8.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET, BY SOURCE 90
FIGURE 27 BEEF EXPORTS FROM BRAZIL (1,000 TONS) 90
9 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION 91
9.1 INTRODUCTION 92
FIGURE 28 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION 92
9.2 BLOOM VALUE 93
9.2.1 HIGH BLOOM 93
9.2.2 LOW BLOOM 93
TABLE 30 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION,
2018–2025 (USD MILLION) 93
9.3 STABILIZING AGENTS 93
9.3.1 THE HIGH SHARE OF GELATIN IN THIS SEGMENT CAN BE ATTRIBUTED TO UTILITY AS A STABILIZING AGENT FOR CAPSULES AND VACCINES 93
TABLE 31 STABILIZING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 94
9.4 THICKENING AGENTS 94
9.4.1 THE RISING USE OF SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE THE GROWTH OF THIS FUNCTIONAL SEGMENT IN THE PHARMACEUTICAL GELATIN MARKET 94
FIGURE 29 VISCOSITY BEHAVIOR OF GELATIN AS A FUNCTION OF TEMPERATURE AT 60OC 95
TABLE 32 THICKENING AGENT MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
9.5 GELLING AGENTS & OTHER FUNCTIONS 96
9.5.1 THE UNIQUE GELLING PROPERTY OF GELATIN FINDS A SIGNIFICANT NUMBER OF APPLICATIONS IN THE FORMATION OF SOFTGEL CAPSULES AND HEMOSTATS 96
TABLE 33 GELLING AGENTS & OTHER FUNCTIONS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 97
10 PHARMACEUTICAL GELATIN MARKET, BY TYPE 98
10.1 INTRODUCTION 99
FIGURE 30 PRODUCTION PROCESS: TYPE A AND TYPE B GELATIN 99
TABLE 34 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: HARD CAPSULES 100
TABLE 35 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: SOFTGEL CAPSULES 100
TABLE 36 SPECIFICATIONS FOR PHARMACEUTICAL-GRADE GELATIN: TABLET GELATIN 100
TABLE 37 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018–2025 (USD MILLION) 101
10.2 TYPE B 101
10.2.1 THE RISING DEMAND FOR BOVINE SOURCE RAW MATERIAL PROJECTED TO DRIVE THE GROWTH OF TYPE B GELATIN DURING THE FORECAST PERIOD 101
TABLE 38 NUTRITIONAL COMPOSITION OF TYPE B GELATIN 101
TABLE 39 TYPE B GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 102
10.3 TYPE A 102
10.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN IS FAVORING GROWTH IN THE MARKET 102
TABLE 40 NUTRITIONAL COMPOSITION OF TYPE A GELATIN 103
TABLE 41 TYPE A GELATIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 103
11 PHARMACEUTICAL GELATIN MARKET, BY REGION 104
11.1 INTRODUCTION 105
FIGURE 31 INDIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD IN THE PHARMACEUTICAL GELATIN MARKET (IN TERMS OF VALUE) 106
TABLE 42 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION,
2018–2025 (USD MILLION) 106
TABLE 43 PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2025 (KT) 107
11.2 NORTH AMERICA 107
11.2.1 THE LARGE MARKET SHARE OF THE NORTH AMERICAN REGION CAN BE ATTRIBUTED TO THE HIGH R&D INVESTMENTS 107
FIGURE 32 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT 108
TABLE 44 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 45 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE,
BY APPLICATION, 2018–2025 (USD MILLION) 109
TABLE 46 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION) 109
TABLE 47 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION) 109
TABLE 48 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 110
11.2.2 US 110
11.2.2.1 Rising concerns in arthritis and obesity to drive the gelatin market in the US 110
TABLE 49 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,
2018–2025 (USD MILLION) 111
TABLE 50 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 111
TABLE 51 US: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 111
TABLE 52 US: PHARMACEUTICAL MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 112
11.2.3 CANADA 112
11.2.3.1 Rising domestic demand for pharmaceutical products to drive the growth of the pharmaceutical gelatin market 112
TABLE 53 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 112
TABLE 54 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 113
TABLE 55 CANADA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 113
TABLE 56 CANADA: PHARMACEUTICAL MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 113
11.3 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN NORTH AMERICA 114
11.4 EUROPE 114
11.4.1 RELIABLE AVAILABILITY OF RAW MATERIAL AND RISING DEMAND FOR MEDICATION IS DRIVING THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET IN THE EUROPEAN REGION 114
FIGURE 33 EUROPE: PHARMACEUTICAL GELATIN MARKET SNAPSHOT 115
TABLE 57 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY,
2018–2025 (USD MILLION) 116
TABLE 58 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 116
TABLE 59 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 117
TABLE 60 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 117
TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 117
11.4.2 GERMANY 118
11.4.2.1 Growth of the pharmaceutical industry in Germany to drive the demand for gelatin 118
TABLE 62 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 118
TABLE 63 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 119
TABLE 64 GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 119
TABLE 65 GERMANY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 119
11.4.3 FRANCE 120
11.4.3.1 High beef production in France to drive the pharmaceutical gelatin market 120
TABLE 66 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 120
TABLE 67 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 121
TABLE 68 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 121
TABLE 69 FRANCE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 121
11.4.4 UK 122
11.4.4.1 Higher healthcare spending and medicine consumption fuels pharmaceutical gelatin market growth 122
TABLE 70 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,
2018–2025 (USD MILLION) 122
TABLE 71 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 123
TABLE 72 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 123
TABLE 73 UK: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 123
11.4.5 ITALY 124
11.4.5.1 Growth of the pharmaceutical manufacturing industry to fuel the demand for gelatin 124
TABLE 74 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,
2018–2025 (USD MILLION) 124
TABLE 75 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 125
TABLE 76 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 125
TABLE 77 ITALY: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 125
11.4.6 SPAIN 126
11.4.6.1 Abundance of porcine raw material to drive the market for gelatin in Spain 126
TABLE 78 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION,
2018–2025 (USD MILLION) 126
TABLE 79 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 127
TABLE 80 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 127
TABLE 81 SPAIN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 127
11.4.7 REST OF EUROPE 128
11.4.7.1 High consumption and production to drive the growth of the pharmaceutical gelatin market in Rest of Europe 128
TABLE 82 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 128
TABLE 83 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION) 129
TABLE 84 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION) 129
TABLE 85 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE
2018–2025 (USD MILLION) 129
11.5 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN EUROPE 130
11.6 ASIA PACIFIC 130
11.6.1 INCREASE IN CHRONIC ILLNESSES AND DEMAND FOR MEDICATION BOOSTS THE GROWTH OF THE PHARMACEUTICAL GELATIN MARKET 130
FIGURE 34 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT 131
TABLE 86 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 131
TABLE 87 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION) 132
TABLE 88 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION) 132
TABLE 89 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION) 132
TABLE 90 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 133
11.6.2 CHINA 133
11.6.2.1 China’s large population and rise in chronic diseases drive the market for gelatin 133
TABLE 91 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION) 134
TABLE 92 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 134
TABLE 93 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 134
TABLE 94 CHINA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 135
11.6.3 JAPAN 135
11.6.3.1 Increasing aging population drives the market for pharmaceutical gelatin 135
TABLE 95 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION) 136
TABLE 96 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 136
TABLE 97 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 136
TABLE 98 JAPAN: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 137
11.6.4 INDIA 137
11.6.4.1 The booming pharmaceutical industry in the country propels the growth of the pharmaceutical gelatin market 137
TABLE 99 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION
2018–2025 (USD MILLION) 138
TABLE 100 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE,
2018–2025 (USD MILLION) 138
TABLE 101 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION,
2018–2025 (USD MILLION) 138
TABLE 102 INDIA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 139
11.6.5 REST OF ASIA PACIFIC 139
11.6.5.1 Australian and Vietnamese pharmaceutical industries drive the demand for pharmaceutical gelatin 139
TABLE 103 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE,
BY APPLICATION 2018–2025 (USD MILLION) 140
TABLE 104 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE,
BY SOURCE, 2018–2025 (USD MILLION) 140
TABLE 105 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE,
BY FUNCTION, 2018–2025 (USD MILLION) 140
TABLE 106 REST OF ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 141
11.7 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE ASIA PACIFIC REGION 141
11.8 REST OF THE WORLD 142
TABLE 107 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION 2018–2025 (USD MILLION) 142
TABLE 108 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE,
BY APPLICATION 2018–2025 (USD MILLION) 142
TABLE 109 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION) 143
TABLE 110 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE,
BY FUNCTION, 2018–2025 (USD MILLION) 143
TABLE 111 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 143
11.8.1 LATIN AMERICA 144
11.8.1.1 High availability of raw material drives the growth of the pharmaceutical gelatin market in Latin America 144
TABLE 112 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION 2018–2025 (USD MILLION) 144
TABLE 113 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018–2025 (USD MILLION) 145
TABLE 114 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018–2025 (USD MILLION) 145
TABLE 115 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE,
2018–2025 (USD MILLION) 145
11.8.2 MIDDLE EAST & AFRICA 146
11.8.2.1 Rising popularity of halal gelatin drives the growth of the pharmaceutical gelatin market in the Middle East 146
TABLE 116 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE,
BY APPLICATION 2018–2025 (USD MILLION) 146
TABLE 117 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE,
BY SOURCE, 2018–2025 (USD MILLION) 147
TABLE 118 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE,
BY FUNCTION, 2018–2025 (USD MILLION) 147
TABLE 119 MIDDLE EAST & AFRICA: PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 147
11.9 IMPACT OF COVID-19 ON THE PHARMACEUTICAL GELATIN MARKET IN THE REST OF THE WORLD 148
12 COMPETITIVE LANDSCAPE 149
12.1 OVERVIEW 149
FIGURE 35 KEY DEVELOPMENTS IN THE GLOBAL PHARMACEUTICAL GELATIN MARKET, 2017–2020 149
FIGURE 36 MARKET EVALUATION FRAMEWORK: EXPANSIONS DOMINATED THE MARKET IN 2018 AND 2019 150
12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 151
12.3 PRODUCT BENCHMARKING 152
12.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHICAL ASSESSMENT 153
12.5 COMPETITIVE SITUATIONS AND TRENDS 153
TABLE 120 PRODUCT LAUNCHES (2018-2020) 153
TABLE 121 EXPANSIONS (2018–2019) 154
TABLE 122 ACQUISITIONS (2018) 154
TABLE 123 AGREEMENTS (2017) 155
TABLE 124 OTHER DEVELOPMENTS (2020) 155
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 156
13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY 156
13.2 PHARMACEUTICAL GELATIN MARKET SHARE 156
FIGURE 39 PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYERS (2019) 156
13.3 COMPETITIVE LEADERSHIP MAPPING 157
13.3.1 STARS 157
13.3.2 EMERGING LEADERS 157
13.3.3 PERVASIVE 158
13.3.4 EMERGING COMPANIES 158
FIGURE 40 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION MATRIX, 2019 158
13.4 COMPANY PROFILES 159
(Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view)
13.4.1 DARLING INGREDIENTS INC. 159
FIGURE 41 DARLING INGREDIENTS INC.: COMPANY SNAPSHOT (2019) 159
13.4.2 NITTA GELATIN INC. 163
FIGURE 42 NITTA GELATIN INC: COMPANY SNAPSHOT (2020) 163
13.4.3 TESSENDERLO GROUP 166
FIGURE 43 TESSENDERLO GROUP: COMPANY SNAPSHOT (2019) 166
13.4.4 GELITA AG 169
13.4.5 WEISHARDT 172
13.4.6 TROBAS GELATINE B.V. 174
13.4.7 LAPI GELATINE S.P.A 175
13.4.8 INDIA GELATINE & CHEMICALS LTD. 176
FIGURE 44 INDIA GELATINE & CHEMICALS LTD.: COMPANY SNAPSHOT (2020) 176
13.4.9 GELNEX INDUSTRIA E COMERCIO LTDA 177
13.4.10 JUNCA GELATINES SL 178
13.4.11 ITALGELATINE S.P.A. 179
13.4.12 XIAMEN GELKEN GELATIN CO. LTD. 180
13.4.13 GELCO INTERNATIONAL 181
13.4.14 HENAN BOOM GELATIN CO. LTD. 182
13.4.15 BAOTOU DONGBAO BIO-TECH CO. LTD. 183
FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: COMPANY SNAPSHOT (2019) 183
13.4.16 ASPIRE PHARMACEUTICALS 184
13.4.17 NORLAND PRODUCTS, INC. 184
13.4.18 GELTECH CO. LTD. 184
13.4.19 GELIKO LLC 185
13.4.20 KENNEY & ROSS LIMITED 185
*Details on Business and financial overview, Products offered, Recent developments, SWOT analysis, and MNM view might not be captured in case of unlisted companies.
14 APPENDIX 186
14.1 INSIGHTS OF INDUSTRY EXPERTS 186
14.2 DISCUSSION GUIDE 187
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 191
14.4 AVAILABLE CUSTOMIZATIONS 193
14.5 RELATED REPORTS 193
14.6 AUTHOR DETAILS 194



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医薬品用ゼラチンの世界市場予測(〜2025):ソース別(ブタ、ウシ皮、ウシ骨、魚、家禽)、用途別(ハードカプセル、ソフトカプセル、タブレット、吸収性止血鉗子)、機能別(安定化、増粘、ゲル化)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆